Health in Peru 1,269 indicators covering health for Peru. IndicatorLatest Year10-yr change Rank Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 34th Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 42nd Most sold brand of cigarettes - taxes as a % of price - value added ta 0.1% 2020 down 6.2% 48th Most sold brand of cigarettes - taxes as a % of price - specific excis 0.5% 2020 up 67.7% 19th Most sold brand of cigarettes - price in US$ at official exchange rate 3.48 2020 up 118.9% 82nd Number healthy diet unaffordable 11.30 million 2024 up 8.7% 39th Import of environmentally sound technologies 2.41 billion 2020 up 20.6% 56th Percentage of people living with HIV who know their HIV status 85 2025 up 28.8% 65th Percentage of people living with HIV who know their status receiving a 93 2025 up 17.7% 53rd Most sold brand of cigarettes - price in PPP$ 6.86 2020 up 128.7% 76th Export of environmentally sound technologies 511.57 million 2020 up 55.8% 64th Pcv3 number unvaccinated 107,378 2023 up 27.4% 35th Reported number of human rabies deaths 2 2024 — 42nd Proportion of births delivered in a health facility (Facility births) 93.3% 2022 up 7.5% 79th Number of non-autochthonous leprosy cases 5 2024 — 20th Prevalence of wasting, weight for height, female 0.5% 2023 up 66.7% 82nd Prevalence of wasting, weight for height, male 0.7% 2023 up 16.7% 83rd Number reported cases of cholera 16 2002 down 100.0% 48th Maternal mortality ratio 87.4 2021 down 5.7% 17th Population with basic handwashing facilities at home 72.3% 2024 up 46.6% 48th Prevalence of severe wasting, weight for height, female 0.0% 2023 down 100.0% 78th Prevalence of severe wasting, weight for height, male 0.0% 2023 down 100.0% 80th Prevalence of overweight, weight for height, female 6.9% 2023 down 4.2% 25th Prevalence of overweight, weight for height, male 8.1% 2023 down 16.5% 23rd HPV immunization coverage estimates among primary target cohort (9-14 80.0% 2025 up 9.6% 38th Prevalence of underweight, weight for age, female 2.4% 2023 down 20.0% 67th Prevalence of underweight, weight for age, male 2.9% 2023 down 32.6% 69th Prevalence of stunting, height for age, female 10.5% 2023 down 36.7% 62nd Prevalence of stunting, height for age, male 12.5% 2023 down 32.4% 63rd Life expectancy at birth oecd 72.4 2022 down 2.3% 45th How many health warnings are approved by the law for cigarette packagi 12 2022 unchanged 48th Tuberculosis - new and relapse cases 31,241 2011 down 16.0% 28th Number of reported cholera deaths 0 2002 down 100.0% 37th Physiotherapists 1,630 2023 — 48th Diarrhea treatment 22.4% 2020 down 30.4% 84th Pregnant women receiving prenatal care 98.1% 2020 up 3.6% 20th Coverage of the human papillomavirus vaccine 99 2024 up 22.2% 1st Generalist medical practitioners 32,507 2023 — 20th Percentage of principal display area mandated to be covered by health 50 2022 unchanged 80th Average of 13 International Health Regulations core capacity scores 65.84 2017 up 6.2% 106th New cases: pulmonary smear-negative 3,942 2012 down 27.9% 39th Estimated number of pregnant women living with HIV needing antiretrovi 1,400 2025 up 40.0% 46th Percentage of principal display area mandated to be covered by health 50 2022 unchanged 73rd Percentage of principal display area mandated to be covered by health 50 2022 unchanged 80th Average death rate due to natural disasters 0.2818 2021 down 40.7% 75th Total number of notified TB cases 31,461 2014 down 10.4% 29th The number of people with susceptibility test result for rifampicin am 13,453 2021 — 18th Estimated number of pregnant women living with HIV 78 2025 up 20.0% 50th Specialist medical practitioners 24,621 2023 — 34th New cases: pulmonary smear unknown/not done 614 2012 down 38.9% 29th Smear-positive tuberculosis treatment-success rate 74.0% 2011 down 17.8% 126th Share of one year olds who received the rotavirus vaccine 82 2024 down 4.7% 55th How many health warnings are approved by the law for other smoked toba 12 2022 unchanged 49th Insufficiently active 84.72 2016 up 0.1% 51st Percentage of principal display area mandated to be covered by health 50 2022 unchanged 67th The number of people with susceptibility test result for rifampicin am 94.02 2021 — 55th Contraceptive prevalence, any method 54.6% 2022 up 6.1% 14th Percentage of principal display area mandated to be covered by health 50 2022 unchanged 67th Percentage of principal display area mandated to be covered by health 50 2022 unchanged 65th Medical doctors 42.0% 2024 up 10.2% 66th ← Previous Page 17 of 22 Next →